Microbiology Testing Market to Grow with a CAGR of 6.41% through 2029
Increasing concerns about foodborne illnesses and
increase in the growth of the food processing and manufacturing industry is
expected to drive the India Microbiology Testing Market growth in the forecast
period, 2024-2028.
According to TechSci Research report, “Microbiology
Testing Market – India Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2028”, the India Microbiology Testing Market stood at
USD 130.59 million in 2022 and is anticipated to grow with a CAGR of 6.41% in
the forecast period, 2024-2028. The awareness among individuals regarding
Microbiology Testing has led to favorable market conditions for the India
Microbiology Testing market. Several factors contribute to the growth of
various Microbiology Testing products.
The India Microbiology Testing Market is intricately
linked to the country's escalating disease burden. Microbiology testing has
emerged as a critical tool in disease management, offering early detection,
monitoring of antibiotic resistance, and outbreak control. With ongoing
advancements and investments, the market is poised for substantial growth,
contributing to India's efforts to combat the rising health challenges it
faces.
Food safety regulations in the India Microbiology
Testing Market are comprehensive and stringent, overseen by the FSSAI and state
food authorities. Microbiology testing plays a central role in ensuring
compliance with these regulations, from pathogen detection to quality control.
As India's food industry evolves, microbiology testing will remain critical in
safeguarding public health and maintaining the integrity of the food supply
chain, which will further fuel market growth.
In September 2023, BD India launched the BD FACSVerse™
Flow Cytometer, a new flow cytometer that is designed to be affordable and easy
to use. The BD FACSVerse™ Flow Cytometer is ideal for use in a variety of
settings, including hospitals, clinics, and research laboratories. It can be
used for a wide range of applications, including the diagnosis and monitoring
of blood cancers, infectious diseases, and autoimmune diseases.
Indian pharmaceutical industry has emerged as a global
player over the years. Known for its cost-effective manufacturing capabilities
and a strong focus on research and development, it has become a hub for
pharmaceutical production. The industry encompasses the production of generic
drugs, active pharmaceutical ingredients (APIs), and biosimilars, serving both
domestic and international markets.
In today's fast-paced world, infectious diseases can
rapidly spread and cause public health crises, microbiology testing is critical
for diagnosing infections swiftly. Rapid identification of pathogens, such as
bacteria, viruses, and fungi, enables healthcare providers to initiate
appropriate treatments promptly, preventing the spread of diseases.
Microbiology testing aids in antibiotic stewardship, a crucial practice in a
world grappling with antibiotic resistance. By conducting antimicrobial
susceptibility testing (AST), microbiologists help healthcare professionals
choose the most effective antibiotics, avoiding the overuse of broad-spectrum
antibiotics that contribute to resistance. In the fast-paced food industry,
microbiology testing ensures that food products meet safety standards. It
allows for the detection of harmful microorganisms like Salmonella and E. coli,
preventing foodborne outbreaks and ensuring the safety of consumers. The
pharmaceutical industry operates in a high-paced environment where product
quality is paramount. Microbiology testing is indispensable for ensuring the
sterility of drugs, assessing microbial contamination in raw materials, and
verifying the quality of pharmaceutical products.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "India Microbiology Testing Market.”
The pharmaceutical sector in India has seen remarkable
growth, and microbiology testing has been integral to this success. As the
industry continues to evolve, the synergy between pharmaceuticals and
microbiology testing will play a pivotal role in shaping its future, ensuring
that it continues to meet global healthcare needs.
In recent times, microbiology testing has led to the
emergence of rapid diagnostic techniques. Molecular biology methods, such as
polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs),
enable the rapid identification of pathogens, including viruses and bacteria.
This speed is particularly vital during outbreaks, such as the COVID-19
pandemic, where timely diagnosis is crucial for containment and treatment.
Microbiology testing has contributed to the era of precision medicine by allowing
healthcare providers to tailor treatments to individual patients. Genetic
sequencing and microbial profiling help identify specific strains of pathogens
and their antibiotic resistance profiles. This information guides the selection
of targeted therapies, improving treatment outcomes and minimizing side
effects. With the global concern of antibiotic resistance, microbiology testing
has become central to antibiotic stewardship programs. Hospitals and healthcare
facilities use microbiology testing to identify the causative pathogens of
infections and determine their susceptibility to antibiotics. This ensures the
appropriate and judicious use of antibiotics, helping to slow the development
of resistance. However, the Regulatory Compliance and Stringency may hinder
market growth. Moreover, challenges related to Technological Advancements and
Infrastructure may pose obstacles to the Microbiology Testing market in the
near future.
The India Microbiology Testing Market is segmented
into test type, product, indication, application, end-user, regional
distribution, and company.
Based on its test type, Bacterial testing is paramount
in healthcare and clinical diagnostics. It includes the identification and
characterization of bacterial pathogens responsible for various infectious
diseases. Timely and accurate diagnosis of bacterial infections is critical for
patient care, treatment decisions, and the prevention of outbreaks. Hospitals,
diagnostic laboratories, and healthcare facilities heavily rely on bacterial
testing to diagnose conditions such as urinary tract infections, respiratory
tract infections, sepsis, and gastrointestinal infections. Additionally,
antimicrobial susceptibility testing (AST) helps guide physicians in choosing
the most effective antibiotics, especially in an era of rising antibiotic
resistance. Bacterial infections are widespread in India, making up a
significant portion of the country's disease burden. This prevalence drives the
demand for bacterial testing, leading to the dominance of this segment within
the microbiology testing market.
Based on region, West India segment is expected to
grow during the forecast period. Maharashtra, with its economic
capital Mumbai, has historically been a key player in India's healthcare and
pharmaceutical sectors. The state houses numerous hospitals, diagnostic
centers, research institutions, and pharmaceutical companies, making it a
significant hub for microbiology testing. The high population density,
urbanization, and industrialization in Maharashtra contribute to a substantial
demand for microbiology testing services. Hospitals and diagnostic centers in
cities like Mumbai and Pune have well-established microbiology laboratories
catering to diverse healthcare needs. Maharashtra is a major pharmaceutical
manufacturing hub, and quality control and microbiology testing are integral to
pharmaceutical production. The pharmaceutical sector's presence drives the
demand for microbiology testing, particularly in drug manufacturing and quality
assurance.
The South India market is poised to be the
fastest-growing market, offering lucrative growth opportunities for
Microbiology Testing Market players during the forecast period. Factors such as
South Indian states have made substantial investments in healthcare
infrastructure, including hospitals, diagnostic centers, and research
institutions. This expansion leads to increased demand for microbiology testing
services. South India has a growing pharmaceutical and biotechnology sector,
with companies engaged in research, development, and manufacturing. This
sector's growth drives the need for microbiology testing for quality control
and research purposes. The region is home to renowned educational and research
institutions, fostering collaborations in microbiology research. This
contributes to the demand for advanced microbiology testing methodologies.
South India attracts a significant number of medical tourists due to its
world-class healthcare facilities. These facilities require state-of-the-art
microbiology testing services, further boosting the market.
Major companies operating in India Microbiology
Testing Market are:
- Cepheid India Private Limited
- BD India Private Limited
- BIO-RAD LABORATORIES (INDIA) PRIVATE
LIMITED.
- Dr. Reddy's Laboratories Limited
- Biocon Limited
- Abbott India Limited
- Beckman Coulter India Private Limited.
- Agilent Technologies India Private
Limited.
- Neogen Chemicals Limited.
- Thermo Fisher Scientific India Private
Limited
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The need to assess and control microbial
contamination and growing awareness of infectious diseases are key drivers of
the Microbiology Testing market. In recent years, the growing ongoing research
in biotechnology, pharmaceuticals, and biopharmaceuticals relies heavily on
microbiology testing for product development and safety assessment. Moreover,
the growing consumer emphasis on preventative healthcare products has enhanced
production and marketing efforts. To meet the demands of the market, manufacturers
are increasingly incorporating cutting-edge technologies with high production
efficiency. Rising consumer acceptance and continuous product innovation will
further ensure the growth of the Microbiology Testing and supplements market in
the coming years.,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“India Microbiology Testing Market Segmented By Type
(Bacterial, Viral, Fungal), By Product (Instruments, Reagents), By Indication
(Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infection, Periodontal Diseases,
Others), By Application (Pharmaceutical, Food Testing, Clinical, Energy,
Chemical and Material Manufacturing, Environmental), By End-User (Hospitals and
Diagnostic Centers, Custom Lab Service Providers, Academic, and Research Institutes),
By Country, Competition, Forecast, Opportunities, 2019-2029F”, has evaluated
the future growth potential of India Microbiology Testing Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India Microbiology Testing Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com